- Abstract Number: 11
Safety of Adalimumab ± Methotrexate for the Treatment of Polyarticular Juvenile Idiopathic Arthritis (pJIA): STRIVE Registry
- Abstract Number: 45
Safety of Adalimumab in Pediatric Patients with Polyarticular Juvenile Idiopathic Arthritis, Enthesitis-Related Arthritis, Psoriasis, and Crohn’s Disease
- Abstract Number: 121
Safety Of Biological Response Modifiers In Childhood Autoimmune Rheumatic Diseases From A Single North Indian Centre
- Abstract Number: 10
Severe Juvenile Arthritis Associated with a De Novo Gain-of-Function Germline Mutation in MYD88
- Abstract Number: 151
Severe Phenotype of Mevalonate-kinase Deficiency in the Czech Republic
- Abstract Number: 59
Six Minute Walk Test in Children with Juvenile Idiopathic Arthritis
- Abstract Number: 29
Spinal Cord Inflammation in Children with Small Vessel Primary CNS Vasculitis
- Abstract Number: 160
Stepping Stones to Transition Smartly
- Abstract Number: 72
Systemic Juvenile Idiopathic Arthritis in a Colombian cohort: onset and clinical course
2017 Pediatric Rheumatology Symposium
May 17-20, 2017 in Houston, Texas